Navigation Links
Luminex Corporation Reports First Quarter 2011 Results
Date:5/9/2011

h, including the genomics and proteomics research markets.  The Company's xMAP technology is sold worldwide and is in use in leading research laboratories as well as major pharmaceutical, diagnostic and biotechnology companies.  Further information on Luminex or xMAP can be obtained on the Internet at http://www.luminexcorp.com.

Statements made in this release that express Luminex' or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements. Forward-looking statements in this release include statements regarding: the expansion of our installed base; expanded distribution for our MAGPIX system; the development progress of our Gastrointestinal Pathogen Panel and NeoPlex4 assay products; anticipated FDA clearance and market acceptance of our RVP FAST assay product; the ability of our investment in current initiatives and new products to deliver high performance solutions, and drive long-term value for our shareholders; and, projected 2011 revenue. The words "believe," "expect," "intend," "estimate," "anticipate," "will," "could," "should" and similar expressions are intended to further identify such forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.  It is important to note that the Company's actual results or performance could differ materially from those anticipated or projected in such forward-looking statements.  Factors that could cause Luminex' actual results or performance to differ materially include risks and uncertainties relating to, among others, market demand and acceptance of Luminex' products and technology, the Company's dependence on strategic partners for development, commercialization and distribution of products, concentration of the Company's revenue in a limited number of strategic partners, fluctuations in quarterly results due to a lengthy and unpredictable
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011
2. Luminex Corporation Wins Prestigious Medical Design Excellence Award
3. Luminex Corporation to Present at Cowen and Companys 31st Annual Health Care Conference
4. Luminex Corporation Ranked One of the 25 Fastest-Growing Technology Companies in America by Forbes for Third Consecutive Year
5. Luminex and Partners HealthCare Announce Collaboration Agreement
6. Luminex Corporation Reports Fourth Quarter and Full Year 2010 Results
7. Luminex Corporation Fourth Quarter and Full Year 2010 Earnings Release Scheduled for February 7, 2011
8. Luminex Corporation to Present at JP Morgan Healthcare Conference
9. Luminex and One Lambda Renew Long-Term Strategic Partnership
10. Luminex Corporation Board of Directors Authorizes Share Repurchase Plan Through November 2011
11. Luminex Corporation Launches New FDA Cleared Pharmacogenetic Diagnostic Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014  DNAtrix, Inc., experts ... first patient was treated with the company,s lead ... interferon in a randomized, multicenter, open-label Phase Ib ... "DNAtrix, in collaboration with leading neurosurgeons and neuro-oncologists ... initiation of our randomized Phase Ib study of ...
(Date:9/16/2014)... NEW YORK , Sept. 16, 2014  Relmada ... therapies for the treatment of chronic pain, announced today ... Sloan Kettering Cancer Center (MSKCC) in a series of ... ER, a new tamper-resistant, extended release form of levorphanol. ... investigator for these studies. Dr. Pasternak ...
(Date:9/16/2014)... 16, 2014  Eli Lilly and Company (NYSE: ... an agreement to co-develop and commercialize AZD3293, an ... in development as a potential treatment for Alzheimer,s ... is characterized by the accumulation of amyloid plaque ... with the development of beta-amyloid. Inhibiting BACE is ...
Breaking Medicine Technology:DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 2Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 4
... for inherited conditions, ROCHESTER, Minn., Sept. 11 ... can be used to regenerate,heart tissue to treat ... was expedited by the editors of Stem Cells ... journal,s Web site at, http://stemcells.alphamedpress.org/ ., The ...
... PURCHASE, N.Y., Sept. 11 Nutrition 21, ... marketer of nutritional supplements under,the Iceland Health ... manage blood sugar levels, improve cardiovascular health, ... today that study results,released by the National ...
Cached Medicine Technology:Stem Cell Regeneration Repairs Congenital Heart Defect 2Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate 2Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate 3Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate 4
(Date:9/16/2014)... 16, 2014 Programs and policies that ... of billions of dollars in savings for the US ... Commonwealth Fund. To help spur these types of improvements, ... 10 collaborative groups from across the country to field ... ) - a handbook designed to assist groups working ...
(Date:9/16/2014)... NY (PRWEB) September 16, 2014 Seven ... around the world will be honored in New York ... ( http://www.worldofchildren.org ), the only global recognition and funding ... , Hailed by the media as the “Nobel Prize ... have each created life-changing programs that benefit children in ...
(Date:9/16/2014)... This year’s theme is centered around entrepreneurism and ... Pennsylvania, September 15, 2014- Holganix, an elite member of ... companies in the country, produces an organic Bionutritional product ... by naturally decreasing disease and insect damage though significant ... it will hold its third annual Bionutritional Summit at ...
(Date:9/16/2014)... Who:, The Pulmonary Hypertension Association (PHA), ... Children’s Hospital Colorado are hosting Colorado PH in the ... association that works to find ways to prevent and cure ... affects the functioning of the heart and can lead to ... years. , What:, Colorado PH in the Park 2014 ...
(Date:9/16/2014)... 16, 2014 AcousticSheep LLC, makers of ... launch RunPhones® Wireless, their latest version of RunPhones® headphones. ... headband for active people seeking a safe, comfortable headphone. ... on the market and will be available October 1, ... has all of the same great features as its ...
Breaking Medicine News(10 mins):Health News:NQF Seeks Field Testing Groups for Population Health Guide 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 3Health News:World of Children® Award Announces 2014 Honorees 2Health News:World of Children® Award Announces 2014 Honorees 3Health News:World of Children® Award Announces 2014 Honorees 4Health News:World of Children® Award Announces 2014 Honorees 5Health News:World of Children® Award Announces 2014 Honorees 6Health News:World of Children® Award Announces 2014 Honorees 7Health News:World of Children® Award Announces 2014 Honorees 8Health News:Holganix Holds 3rd Annual Bionutritional Summit in Louisville, Kentucky 2Health News:Help Fight Pulmonary Hypertension at the Colorado PH in the Park 2014 2Health News:RunPhones® Prepares to Launch Their New Highly Anticipated Wireless Headphones 2Health News:RunPhones® Prepares to Launch Their New Highly Anticipated Wireless Headphones 3
... Your Medicines and You, Event Provides Free Pharmacist Reviews ... Mistakes, CHICAGO, Oct. 31 The following is ... one of the leading causes of death for,individuals over ... are teaming,up this Thursday to help people better manage ...
... Oct. 31 Varian, Inc.,(Nasdaq: VARI ) ... TOP-DNA and TOP-RNA, for the purification of,synthetic oligonucleotides ... used by life science researchers to,study the functions ... to work,properly, salts and incomplete products need to ...
... 11:01 AM October 31, 2007, WASHINGTON, ... of AARP told lawmakers what American families,already know ... our country is,the skyrocketing costs of health care., ... CEO Bill Novelli testified at a Senate Budget ...
... Another Scientific Review ... ... DENVER, Oct. 31 "The WCRF/AICR recommendations about,red meat and cancer are unsubstantiated ... red meat in a healthy,diet that far outweigh anything we,ve seen today. "There ...
... Open-Bore, Design to Bring High-Resolution MR Imaging to More Patients ... ... MALVERN, Pa., Oct. 31 Combining 3 Tesla strength and,sensitivity with a ... a 3 Tesla (T) MRI system with a 70 cm open bore ...
... to ways to treat injury, stroke and even Alzheimer,s, experts ... new U.S. study involving mice suggests the brain,s own stem ... injury. , These neural stem cells work by protecting existing ... team at the University of California, Irvine, were able to ...
Cached Medicine News:Health News:Varian, Inc. Offers New Products for the Rapid Purification of Synthetic Oligonucleotides. 2Health News:AARP CEO Bill Novelli Tells Lawmakers: Controlling Health Care Costs Key to Budget Reform 2Health News:NCBA Statement on 2007 WCRF/AICR Second Expert Report on Food, Nutrition and Physical Activity and the Prevention of Cancer: 2Health News:3 Tesla + 70 cm + Tim = The Most Exciting Equation in MRI 2Health News:3 Tesla + 70 cm + Tim = The Most Exciting Equation in MRI 3Health News:3 Tesla + 70 cm + Tim = The Most Exciting Equation in MRI 4Health News:Stem Cells Restore Memory in Mice 2Health News:Stem Cells Restore Memory in Mice 3
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
... German Craftsmanship have produced ... in the world. Ocutek® ... to you! Only holders ... certificate, which requires and ...
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Medicine Products: